Dr. M.J. Suttorp

Werkzaam op locatie Nieuwegein

Opleiding tot arts
1976 - 1983 University education Study Medicine at  State University of Utrecht

Opleiding tot medisch specialist
1992 PhD thesis, University of Groningen

1986 – 1988 Resident Cardiology St. Antonius Hospital, Nieuwegein (head: dr C.A.P.L. Ascoop, cardiologist)

1983 – 1985 Resident Internal Medicine: Onze Lieve Vrouwe Hospital, Amsterdam
2 year Internal Medicine (head: dr J.P. de Geus, later on dr K.J. Roozendaal, internists)
½ year Pulmonary diseases  (head: dr J.P.M. Wagenaar)

Rahel BM, Laarman GJ, Suttorp MJ, PRISON II study investigators. Primary stenting of occluded native coronary arteries II—rationale and design of the PRISON II study: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions. Am Heart Journal 2005 Mar;149(3):e1- e3 PMID: 15864219

Ackerstaff RGA, Suttorp MJ, van den Berg JC, Overtoom TThC, Vos JA, Bal ET, Zanen P, Antonius Carotid Endarterectomy Angioplasty and Stenting Study Group. Prediction of early cerebral outcome by transcranial Doppler monitoring in carotid bifurcation angioplasty and stenting. Journal of Vascular Surgery 2005; 41(4):618-624

De Ridder S, Suttorp MJ, Ernst SM, Six JA, Mannaerts HF, Kamp O, Plokker HWM, Jaarsma W. Percutaneous transcatheter closure of atrial septal defects: initial single-centre experience and follow-up results. Intitial experience with three-dimensional echocardiography. Acta Cardiologica 2005; 60 (2): 171-178

Vos JA, van den Berg JC, Ernst SMPG, Suttorp MJ, Overtoom TThC, Mauser HW, Vogels OJM, van Heesewijk JPM, Moll FL, van der Graaf Y, Mali WP, Ackerstaff RGA. Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology 2005; 234 (2):493-499  

Dawkins KD, Chevalier B, Suttorp MJ, Thuesen L, Benit E, Bethencourt A, Morjaria U, Veldhof S, Dorange C, van Weert A. Effectiveness of “Direct” Stenting Without Balloon Predilatation (from the Multilink Tetra Randomised European Direct Stent Study [TRENDS]. American Journal of Cardiology 2006; 97(3): 316-321

Post MC, Suttorp MJ, Jaarsma W, Plokker HW. Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defects in adults: A single center experience. Catheterization & Cardiovasculair Interventions 2006; 67(3); 438-443

Lotan C, Almagor Y, Kuiper K, Suttorp M.J. Wijns W. Sirolimus-Eluting Stent in Chronic Total Occlusion: The SICTO Study. J Interv Cardiol. 2006 Aug;19(4):307-12

Sugita J, Cremonesi A, Van Elst F, Stockx L, Mathias K, Schofer J, Suttorp MJ, Reul J, Lowens S, Sievert H. European carotid PROCAR Trial: prospective multicenter trial to evaluate the safety of carotid artery stenosis—1 and 6- month follow-up. J Interv Cardiol. 2006 Juni; 19(3):215-21

Wille J, Vos JA, Overtoom TT, Suttorp MJ, van de Pavoordt ED, de Vries JP. Acute leg ischaemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg. 2006 Mar; 20(2):278-81. Epub 2006 Mar 21.

Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T,   van der Wieken LR, Tijssen JG, Rensing BJ, Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. New England Journal of Medicine 2006; 355 (11) : 1105–1113.

Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, ten Berg JM, Rensing BJ,   Eefting FD, Mast EG. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006; 114 (9):921-928

Swinkels B.M., Suttorp M.J. Percutane aortaklepvervanging is een goede optie bij niet-operabele symptomatische aortaklepstenose. Tijdschr Geneeskd. 2006; 150; 1856-57

Carlos Macaya, MD; Hector M. Garcia-Garcia, MD; Antonio Colombo, MD; Marie-Claude Morice, MD; Victor Legrand, MD; Karl-Heinz Kuck, MD; Imad Sheiban, MD; Maarten Jan Suttorp, MD; Didier Carrie, MD; Mathias Vrolix, MD; Kristel Wittebols, MSc; Hans-Peter Stoll, MD; Dennis Donohoe, MD; Marco Bressers, MSc, Patrick W. Serruys, MD, PhD. One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease. Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I.

J.W. van Werkum, W.B.M. Gerritsen, J.C. Kelder, C.M. Hackeng, S.M. Ernst, V.H.M. Deneer, M.J. Suttorp, B.J.W.M. Rensing, H.W.M. Plokker, J.M.ten Berg. Inhibition of platelet function by abciximab of high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial. Netherlands Heart Journal, 2007; 15 (11); 375- 387

Kastrati A, Mehili J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. New England Journal of Medicine 2007; 356: 1030-1039.

Van Werkum JW, Seesing TH, Suttorp MJ, Bal ET, den Heijer P, Ten Berg JM. Double-trouble: three cases with simultaneous stent thtombosis in different coronary arteries. Journal of Interventional Cardiology; 2007 vol 20; no 2   132-5

Didier Blanchard, MD; Gian Battista Danzi, MD; Philip Urban MD, FESC; Morris Moseri, MD, FESC; Craig Juergens, MD, FACC; Philip Guyon, MD; Bernd Nowak, MD, FESC; Damras Tresukosol, MD, FAPSIC; Maarten J. Suttorp, MD, PhD; Ahmad Farshid, MD; Ran Kornowski, MD, FACC; Eulogio Garcia, MD; Richard Yeend, MD; Hirofumi Nagai, PhD; Dragica Paunovic, MD; on behalf of MATSURI investigators. A novel ultra-thin bare metal stent (BMS): results from a worldwide registry. EuroIntervention; 2007; 3, 1-7.  

Van den Broek T, Liqui Lung PF, Suttorp MJ, Eefting FD, Schipper ME, Vink A. Vascular Occlusion as a late complication of the Angio-Seal closure device. A review of literature. Minerva Cardioangiol. 2007 Dec;55 (6): 815-9

Van der Heijden J, Suttorp MJ, Bal ET, Ernst JM, Ackerstaff RF, Schaap J, Kelder JC, Schepens M, Plokker HW. Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results. Circulation 2007 Oct 30; 116 (18): 2036-42

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Syvanne M, Suttorp MJ, Violoni R, Schomig A. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stent in patients with acute myocardial infarction. European Heart J. 2007 Nov; 28 (22): 2706-13

Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Juni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007 Sep 15; 370 (9591): 937-48 Review

Suttorp MJ, Laarman GJ; Prison III study investigators, A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study. Am Heart J. 2007 Sept; 154 (3): 432-5

Van den Broek T, Liqui Lung PF, Suttorp MJ, Eefting FD, Schipper ME, Vink A. Arterial occlusion after repetitive angio-seal device closure. Vasc Endovascular Surg. 2007 Aug-Sep; 41 (4):346-7

Van Werkum JW, Ten Berg JM, Thijs Plokker HW, Kelder JC, Suttorp MJ, Rensing BJ, Tersmette M. Staphylococcus aureus infection complicating percutaneous coronary interventions. Int J Cardiol. 2007 Jul 26

De Borst GJ, Vos JA, Reichmann B, Hellings WE, de Vries JP, Suttorp MJ, Moll FL, Ackerstaff RG, Antonius Carotid Endarterectomy, Angioplasty, and Stenting Study Group. The fate of the external carotid artery after carotid artery stenting. A follow-up study with duplex ultrasonography. Eur J Vasc Endovasc Surg. 2007 Jun: 33 (6): 657-63

Van Werkum JW, Gerritsen WB, Kelder JC, Hackieng CM, Ernst SM, Deneer VH, Suttorp MJ,   Rensing BJ, Plokker HW, Ten Berg JM. Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial. Neth Heart J. 2007 Nov; 15 ( 11 ): 375-81 . 

Van der Heijden J, Lans HW, van Werkum JW, Schepens M, Ackerstaff RF, Suttorp MJ. Will Carotid Angioplasty Become the Preferred Alternative to Staged Or Synchronous Carotid Endarterectomy in Patients Undergoing Cardiac Surgery? Eur J Vasc Endovasc Surg. 2008 Jul 10. [Epub ahead of print]

Rahel BM, Laarman GJ, Kelder JC, Ten Berg JM, Suttorp MJ. Three-Year Clinical Outcome After Primary Stenting of Totally Occluded Native Coronary Arteries: A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). In press